Pharmafile Logo
Pharmafocus logo
Advanced Search

BioNTech

Showing 7 posts of 22 posts found.

800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …

News
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020
Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …

News
shutterstock

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020
Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News
R&D

Sanofi and BioNTech in cancer immunotherapy partnership

November 3, 2015
Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy

Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …

News
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015
Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …

News
sierk-poetting

BioNTech appoints chief financial officer

September 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting

German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …

Appointment

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024